AL109659.1 | Connexin {ECO:0000313|EMBL:AAK34937.1}; HCG2031517 {ECO:0000313|EMBL:EAX06856.1} | Predicted membrane proteins
| | | | | Not detected |
AL354828.1 | | Predicted membrane proteins
| | | | | Not detected |
AL357140.1 | | Predicted membrane proteins
| | | | | Not detected |
AL365181.2 | | Predicted membrane proteins
| | | | | Mixed |
AL591806.1 | | Predicted membrane proteins
| | | | | Not detected |
AL596220.1 | | Predicted membrane proteins
| | | | | Not detected |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH3A2 | Aldehyde dehydrogenase 3 family, member A2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | Predicted membrane proteins
| | | | | Mixed |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALG5 | ALG5, dolichyl-phosphate beta-glucosyltransferase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Predicted membrane proteins
| | | | | Tissue enhanced |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AMICA1 | Adhesion molecule, interacts with CXADR antigen 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMIGO1 | Adhesion molecule with Ig-like domain 1 | Predicted membrane proteins
| | | | | Mixed |
AMIGO2 | Adhesion molecule with Ig-like domain 2 | Predicted membrane proteins
| | | | | Mixed |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ANAPC1 | Anaphase promoting complex subunit 1 | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
ANKLE1 | Ankyrin repeat and LEM domain containing 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ANKLE2 | Ankyrin repeat and LEM domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANKRD29 | Ankyrin repeat domain 29 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANKRD32 | Ankyrin repeat domain 32 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ANKRD46 | Ankyrin repeat domain 46 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANTXR1 | Anthrax toxin receptor 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ANTXR2 | Anthrax toxin receptor 2 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ANTXRL | Anthrax toxin receptor-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
AP000322.53 | | Predicted membrane proteins
| | | | | Group enriched |
AP005242.1 | | Predicted membrane proteins
| | | | | Not detected |
AP5S1 | Adaptor-related protein complex 5, sigma 1 subunit | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APCDD1 | Adenomatosis polyposis coli down-regulated 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APCDD1L | Adenomatosis polyposis coli down-regulated 1-like | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APMAP | Adipocyte plasma membrane associated protein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL4 | Apolipoprotein L, 4 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
APOO | Apolipoprotein O | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |